Skip to content

Endoscopic drainage of presumed resectable perihilar cholangiocarcinoma using a novel design short fully covered self-expanding metal stent with retrieval string (CHORDA)

Endoscopic drainage of presumed resectable perihilar cholangiocarcinoma using a novel design short fully covered self-expanding metal stent with retrieval string (CHORDA) - CHORDA-pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50887
Enrollment
25
Registered
2021-03-26
Start date
2021-04-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer of the bile ducts Cholangiocarcinoma

Interventions

Unilateral endoscopic drainage of the future liver remnant using a removable FCSEMS (length 4 cm
diameter 8 mm).

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with presumed perihilar cholangiocarcinoma that are judged eligible for major liver resection and require endoscopic biliary drainage of the future liver remnant.

Exclusion criteria

Exclusion criteria: - Incompletely recovered from any side effects of previous biliary drainage procedures - Any contra-indication for major liver surgery - Technical contra-indications for endobiliary drainage - Requirement of multiple stents for adequate drainage of the future liver remnant

Design outcomes

Primary

MeasureTime frame
Primary outcome: number of severe drainage related complications between inclusion and exploratory laparotomy. In patients who will not undergo exploratory laparotomy, the number of drainage-related complications will be measured until 7 days after the decision to cancel exploratory laparotomy or 90 days after inclusion, whichever comes first.

Secondary

MeasureTime frame
Secondary outcome will include technical and therapeutic success of biliary drainage, individual components of primary endpoints and quality of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026